Recent anecdotal and scientific reports have provided evidence of a link between COVID-19
and chemosensory impairments, such as anosmia. However, these reports have …

Background. Clinical trials in renal transplantation must use surrogate markers of long-term
graft survival if conclusions are to be drawn at acceptable speed and cost. Morphologic …

In a preregistered, cross-sectional study, we investigated whether olfactory loss is a reliable
predictor of COVID-19 using a crowdsourced questionnaire in 23 languages to assess …

Anosmia constitutes a prominent symptom of COVID-19. However, anosmia is also a common
symptom of acute colds of various origins. In contrast to an acute cold, it appears from …

Olfactory disorders are believed to affect 5% of the general population and have been shown
to bear significant psychosocial consequences to sufferers. Although more common than …

Background Respiratory tract viruses are the second most common cause of olfactory
dysfunction. As we learn more about the effects of severe acute respiratory syndrome coronavirus …

Background Chronic rhinosinusitis (CRS) is a common disorder associated with other respiratory
tract diseases such as asthma and inhalant allergy. However, the prevalence of these …

Objectives There are large numbers of patients with olfactory disturbance in the UK and
shortfalls in assessment and support amongst mainstream practice in both primary and …

OBJECTIVE: To see if nasal peak inspiratory flow rate and subjective sense of smell had any
correlation with olfactory thresholds. STUDY DESIGN AND SETTING: A cohort study of 186 …

The frequent association between coronavirus disease 2019 (COVID‐19) and olfactory
dysfunction is creating an unprecedented demand for a treatment of the olfactory loss. Systemic …